JP2022541331A5 - - Google Patents

Info

Publication number
JP2022541331A5
JP2022541331A5 JP2022504712A JP2022504712A JP2022541331A5 JP 2022541331 A5 JP2022541331 A5 JP 2022541331A5 JP 2022504712 A JP2022504712 A JP 2022504712A JP 2022504712 A JP2022504712 A JP 2022504712A JP 2022541331 A5 JP2022541331 A5 JP 2022541331A5
Authority
JP
Japan
Application number
JP2022504712A
Other languages
Japanese (ja)
Other versions
JP7649285B2 (ja
JP2022541331A (ja
JPWO2021013972A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/070896 external-priority patent/WO2021013972A1/en
Publication of JP2022541331A publication Critical patent/JP2022541331A/ja
Publication of JP2022541331A5 publication Critical patent/JP2022541331A5/ja
Publication of JPWO2021013972A5 publication Critical patent/JPWO2021013972A5/ja
Application granted granted Critical
Publication of JP7649285B2 publication Critical patent/JP7649285B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504712A 2019-07-25 2020-07-24 エプスタイン・バーウイルス(ebv)を検出するための組成物および方法 Active JP7649285B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962878643P 2019-07-25 2019-07-25
US62/878,643 2019-07-25
PCT/EP2020/070896 WO2021013972A1 (en) 2019-07-25 2020-07-24 Compositions and methods for detection of epstein barr virus (ebv)

Publications (4)

Publication Number Publication Date
JP2022541331A JP2022541331A (ja) 2022-09-22
JP2022541331A5 true JP2022541331A5 (https=) 2023-08-02
JPWO2021013972A5 JPWO2021013972A5 (https=) 2023-08-02
JP7649285B2 JP7649285B2 (ja) 2025-03-19

Family

ID=71833326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504712A Active JP7649285B2 (ja) 2019-07-25 2020-07-24 エプスタイン・バーウイルス(ebv)を検出するための組成物および方法

Country Status (6)

Country Link
US (1) US12571059B2 (https=)
EP (1) EP4004240B1 (https=)
JP (1) JP7649285B2 (https=)
CN (1) CN114174540A (https=)
ES (1) ES2988562T3 (https=)
WO (1) WO2021013972A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10760137B2 (en) * 2017-07-18 2020-09-01 Roche Molecular Systems, Inc. Compositions and methods for detection of Babesia
CN120334544B (zh) * 2025-06-18 2025-09-09 杭州凯保罗生物科技有限公司 鼻咽癌抗体标志物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135587B2 (en) 1983-02-22 2002-12-18 Syngene, Inc. Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4996143A (en) 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5683896A (en) 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
EP1067134B1 (en) 1991-11-07 2004-07-28 Nanotronics, Inc. Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
JP4281877B2 (ja) 1996-06-04 2009-06-17 ユニバーシティ オブ ユタ リサーチ ファウンデーション 生物学的プロセスを実行し且つモニタリングするためのシステムと方法
EP1033411B1 (en) 1996-06-04 2006-02-22 University of Utah Research Foundation Fluorescent donor-acceptor pair
ATE280177T1 (de) 1997-03-20 2004-11-15 Hoffmann La Roche Modifizierte primer
US6753137B2 (en) 2001-01-31 2004-06-22 The Chinese University Of Hong Kong Circulating epstein-barr virus DNA in the serum of patients with gastric carcinoma
WO2007039301A2 (en) 2005-10-05 2007-04-12 Roche Diagnostics Gmbh Non-fluorescent energy transfer
JP5666776B2 (ja) 2005-10-28 2015-02-12 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 齧歯動物細胞におけるタンパク質発現
CN105658816A (zh) 2013-10-04 2016-06-08 世程发展公司 用于鼻咽癌筛查的方法和装置
CN107354239B (zh) 2017-09-19 2020-11-27 中山大学肿瘤防治中心 一种检测eb病毒的多重荧光定量pcr方法及试剂盒

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2022541331A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021016176A2 (https=)